You are here: Industry Insights > Long Covid

News List

Long COVID May Qualify as a Disability: Biden drugs
July 28, 2021
Serious "long COVID" symptoms could qualify as a disability and make patients eligible for federal assistance, President Joe Biden said Monday.
"Long COVID": More than a quarter of COVID-19 patients still symptomatic after 6 months worldpharmanews
July 14, 2021
In a new study of adults from the general population who were infected with COVID-19 in 2020, more than a quarter report not having fully recovered after six to eight months.
Long COVID Dramatically Increases Cases Of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome prnewswire
April 20, 2021
As Long COVID brings renewed attention to the debilitating and chronic illness known as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a record number of advocates are virtually gathering on Capitol Hill for Solve M.E.'s 5th Annual ...
NIHR review identifies long-term effects of COVID-19 pharmatimes
October 16, 2020
A review from the National Institute for Health Research will analyse the evidence around ongoing COVID-19 symptoms, otherwise referred to as ‘Long Covid’.